Drugs / Cellulose Sulfate
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT00255294 | Jan → Oct 2005 | — | CONRAD | Completed | No outcome recorded |
| Phase 32 trials · 2 missed | ||||||
| Phase 3 | NCT00153777 | Jul 2005 → Mar 2007 | HIV infectious disease | CONRAD | Terminated | Missed primary |
| Phase 3 | NCT00120770 | Nov 2004 → Mar 2007 | HIV infectious disease, chlamydia infectious disease, gonorrhea | FHI 360 | Terminated | Missed primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Cellulose Sulfate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00153777 ↗ |
| Action | Inhibit | “cellulose sulfate, an HIV-entry inhibitor formulated as a vaginal gel” PMID 18669425 ↗ Jul 2008 |
| Route | Other | “formulated as a vaginal gel” PMID 18669425 ↗ Jul 2008 |